Submitted: 01 Dec 2021
Accepted: 09 Dec 2021
ePublished: 30 Dec 2021
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Avicenna J Pharm Res. 2021;2(2): 55-59.
doi: 10.34172/ajpr.2021.11
  Abstract View: 159
  PDF Download: 101

Original Article

Retrospective Drug Utilization Evaluation of Vancomycin Usage in Infectious Wards and Intensive Care Units in Hamedan Teaching Hospitals, April to September 2020

Mohammad Amin Ghollar 1 ORCID logo, Maryam Rangchian 2, Maryam Etminaniesfahani 2*

1 School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
2 Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran
*Corresponding Author: Corresponding author: Maryam Etminaniesfahani, Assistant Professor Department of Clinical Pharmacy, School of Pharmacy, Hamadan University of Medical Sciences. Email: , Email: Maryam_etminani@yahoo.com


Background: Drug utilization evaluation (DUE) was performed to assess using drugs with special conditions such as antibiotics. Vancomycin is one of the essential antibiotics that is effective on methicillin-resistant Staphylococcus aureus, but unreasonable use of vancomycin, in addition to cost, leads to outbreak microbial resistance, which is a concern for health care systems all around the world. The aim of this study was to evaluate vancomycin use in teaching hospitals in Hamedan, Iran.

Methods: This retrospective study was performed on patients who received vancomycin for at least 72 hours in intensive care units and infectious wards between April and September 2020 in the teaching hospitals of Hamedan. Data were obtained from patients’ medical records and entered into predesigned checklists.

Results: From 661 patients, 441 were males and 247 were females. They received vancomycin for an average of 5.75 days. The most prevalent indication for vancomycin use was surgery. Only 40 patients had sensitive microbial culture to vancomycin, while 356 of them (53.9%) had no microbial culture at all. According to HICPAC guidelines, the overall appropriate use of vancomycin was 44.8%.

Conclusion: According to the results, the irrational use of vancomycin must be corrected to achieve maximum optimal use; thus, performing and adhering to microbial culture, deploying clinical pharmacists, and holding explanatory sessions for health care are recommended for this purpose.

Please cite this article as follows: Ghollar MA, Rangchian M, Etminaniesfahani M. Retrospective drug utilization evaluation of vancomycin usage in infectious wards and intensive care units in hamedan teaching hospitals, april to september 2020. Avicenna J Pharm Res. 2021; 2(2):55-59. doi:10.34172/ajpr.2021.11
First Name
Last Name
Email Address
Security code

Abstract View: 160

Your browser does not support the canvas element.

PDF Download: 101

Your browser does not support the canvas element.